Using artificial intelligence to learn optimal regimen plan for Alzheimer's disease.

Kritib BhattaraiSivaraman RajaganapathyTrisha DasYejin KimYongbin Chennull nullnull nullQiying DaiXiaoyang LiXiaoqian JiangNansu Zong

Published in: Journal of the American Medical Informatics Association : JAMIA (2023)

Our results highlight the potential of using RL to generate the optimal treatment based on the patients' longitude records. Our work can lead the path towards developing RL-based decision support systems that could help manage AD with comorbidities.

Keyphrases

artificial intelligence
end stage renal disease
machine learning
big data
chronic kidney disease
newly diagnosed
ejection fraction
deep learning
cognitive decline
risk assessment
patient reported outcomes
combination therapy
patient reported
mild cognitive impairment